Pathogenic variants in ATP13A2 define Kufor–Rakeb syndrome (KRS) and are distinct from other PARK genes, which engage in ubiquitin-proteasome pathways, mitochondrial quality control, or synaptic vesicle recycling [3–5]. Here, ATP13A2 is linked to Kufor-Rakeb syndrome.